<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-5QAG32VI/93928129-4a5c-4593-b256-10a4794f7ed9/PDF"><dcterms:extent>527 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-5QAG32VI/ca039fa8-ef1c-49e7-bc60-c88696fc6e74/TEXT"><dcterms:extent>25 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-5QAG32VI"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>1997</dcterms:issued><dc:creator>Bohuslavizki, Karl H...</dc:creator><dc:creator>Brenner, Winfried</dc:creator><dc:creator>Clausen, Malte</dc:creator><dc:creator>Feyerabend, Bernd</dc:creator><dc:creator>Henze, Eberhard</dc:creator><dc:creator>Hübner, Ralf-Harto</dc:creator><dc:creator>Klutmann, Susanne</dc:creator><dc:creator>Lüttges, Jutta</dc:creator><dc:creator>Mester, Janos</dc:creator><dc:creator>Tinnemeyer, Stephan</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:31</dc:format><dc:format xml:lang="sl">str. 279-285</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID_HOST:7387097</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-5QAG32VI</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">Adverse effects</dc:subject><dc:subject xml:lang="sl">Amifostine</dc:subject><dc:subject xml:lang="sl">Iodine radioisotopes</dc:subject><dc:subject xml:lang="sl">Rabbits</dc:subject><dc:subject xml:lang="sl">Radiation effects</dc:subject><dc:subject xml:lang="sl">Radiation-protective agents</dc:subject><dc:subject xml:lang="sl">Radionuclide imaging</dc:subject><dc:subject xml:lang="sl">Radiotherapy</dc:subject><dc:subject xml:lang="sl">Salivary glands</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy investigated in a new rabbit animal model|</dc:title><dc:description xml:lang="sl">Salivary gland damage following high-dose radioiodine treatment (HD-RIT) is a well known side effect. Since differentiated thyroid cancer (DTC) has a very good prognosis, the reduction of long-term side effect is of major interest. Therefore, the radioprotective effect of amifostine was investigated in a rabbit animal model. Quantitative salivary gland scintigraphy was performed on5 rabbits prior to and up to 3 months after HD-RIT applying 1 GBq I-131. Theuptake of Tc-99cm-pertechnetate was calculated as a measure of parenchymal function. Three animals received 200 mg/kg amifostine prior to HD-RIT, and twoserved as controls. Salivary glands were examined histopathologically. In two control rabbits HD-RIT significantly (p&lt;0.001) reduced pertechnetate uptake by 63% and 46% in parotid and submandibular glands, respectively, and lipomatosis was found histopathologically. In contrast, in three rabbits treated with amifostine parenchymal function was not decreased significantly (p=0.953), and lipomatosis was negligible. In conclusion, salivary gland impairment induced by HD-RIT can be evaluated quantitatively by salivary glandscintigraphy in rabbits, and amifostine significantly reduced salivary gland damage induced by HD-RIT. These encouraging results need furtner evaluation in patients since in may help to increase the quality of life of patients with diffentiated thyroid cancer</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-5QAG32VI"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-5QAG32VI" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-5QAG32VI/93928129-4a5c-4593-b256-10a4794f7ed9/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Onkološki inštitut Ljubljana</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-5QAG32VI/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-5QAG32VI" /></ore:Aggregation></rdf:RDF>